Outcomes After Atrial Fibrillation Ablation in Patients With Premature... https://t.co/MHyGkGLJud
@JDMossMD @Ed_Gerst @Zo_EP2 @Dr_Santangeli @rdschaller @JRWinterfield @True_EP Of course it's difficult to know (and study). As far as I know this is one of the few studies on the matter https://t.co/59vroNXBVJ
RT @heart_doc2018: こういう論文は悔しいな。そんなにnが多くない。アイディア勝負な論文だわ。はあ‥出てこいアイディア https://t.co/gfF4Ya1uZh
当院からの報告とはだいぶ、、、笑 誘発の方法や、どのAPCも本当に再発に関与しないのかとか、色々ありますけど、、、 うちももう少しデータ出さないと、、、だな
こういう論文は悔しいな。そんなにnが多くない。アイディア勝負な論文だわ。はあ‥出てこいアイディア
RT @Yuki_Sahashi: 日本から。PVI後のnon PV-PACの残存は特にAF再発率に関与しない。JACC EP アブストだけ読むメモです Outcomes After Atrial Fibrillation Ablation in Patients With…
RT @Yuki_Sahashi: 日本から。PVI後のnon PV-PACの残存は特にAF再発率に関与しない。JACC EP アブストだけ読むメモです Outcomes After Atrial Fibrillation Ablation in Patients With…
How come? #EPeeps, any suggestions? Outcomes After Atrial Fibrillation Ablation in Patients With Premature Atrial Contractions Originating From Non-Pulmonary Veins https://t.co/S3ATt5uJsx
RT @JACCJournals: What is the clinical significance of residual non-pulmonary vein PACs (on isoproterenol 4-20mcg/min) during #AFib procedu…
RT @JACCJournals: What is the clinical significance of residual non-pulmonary vein PACs (on isoproterenol 4-20mcg/min) during #AFib procedu…
RT @JACCJournals: What is the clinical significance of residual non-pulmonary vein PACs (on isoproterenol 4-20mcg/min) during #AFib procedu…
What is the clinical significance of residual non-pulmonary vein PACs (on isoproterenol 4-20mcg/min) during #AFib procedures? #JACCCEP study suggests that residual non-PV PACs do not associate with #Afib recurrence after PVI. https://t.co/9TTFavKtV2 https: